Skip to Content

Chifeng Pharmaceutical Co Ltd, China, 2023

GMP Audit Report

Company
Chifeng Pharmaceutical Co Ltd

Product(s)
Griseofulvin, Oxytetracycline 2AQ

Country
China

Audit Year
2023


0.00 € 0.00 €
0.00 €